252: Pharmacokinetics and pharmacodynamics of intermittent and continuous infusion of vancomycin in adult cystic fibrosis patientsBarry Lindley, D. Young, Kay Gray et al.|Journal of Cystic Fibrosis|2021Cited by 0
P250 Minimum inhibitory concentration targeted antibiotic dose optimization in patients with cystic fibrosisDavid C. Young, Theodore G. Liou, Zubin Bhakta et al.|Journal of Cystic Fibrosis|2023Cited by 0
A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosisS. Sherwood, David C. Young, Casey Tak et al.|Pediatric Pulmonology|2024Cited by 0
P150 Impact of adverse effects on CFTR modulator dosing in people with cystic fibrosis (PwCF)E. Chang, H. R. D. Jacobs, David C. Young et al.|Journal of Cystic Fibrosis|2024Cited by 0
An Observational Cohort Study of Targeted Antibiotic Treatments of Cystic Fibrosis ExacerbationsH. R. D. Jacobs, Theodore G. Liou, Rhonda D. Szczesniak et al.|Open Forum Infectious Diseases|2025Cited by 0